D
David M. Hwang
Researcher at Sunnybrook Health Sciences Centre
Publications - 184
Citations - 9146
David M. Hwang is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Lung transplantation & Lung. The author has an hindex of 48, co-authored 179 publications receiving 7241 citations. Previous affiliations of David M. Hwang include Toronto General Hospital & University Health Network.
Papers
More filters
Journal ArticleDOI
Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation
Masaaki Sato,David M. Hwang,Kaori Ohmori-Matsuda,C. Chaparro,Thomas K. Waddell,Lianne G. Singer,Michael Hutcheon,Shaf Keshavjee +7 more
TL;DR: Early DAD is associated with early mortality and BOS, and late new-onset DAD increases the risk of RAS.
Journal ArticleDOI
The Role of Intrapulmonary De Novo Lymphoid Tissue in Obliterative Bronchiolitis after Lung Transplantation
Masaaki Sato,S. Hirayama,David M. Hwang,Humberto Lara-Guerra,D. Wagnetz,Thomas K. Waddell,Mingyao Liu,Shaf Keshavjee +7 more
TL;DR: De novo lymphoid tissue in the lung is found composed of effector memory T cells and HEVs but lacking delineated T cell and B cell zones, which may play a critical role in chronic local immune responses after lung transplantation.
Journal ArticleDOI
Sample Features Associated with Success Rates in Population-Based EGFR Mutation Testing
Carolyn J. Shiau,Carolyn J. Shiau,Jesse Paul Babwah,Gilda da Cunha Santos,Jenna Sykes,Scott L. Boerner,William R. Geddie,Natasha B. Leighl,Cuihong Wei,Suzanne Kamel-Reid,David M. Hwang,Ming-Sound Tsao +11 more
TL;DR: A large cohort and epidemiologically unselected series of EGFR mutation testing for patients with nonsquamous non–small-cell lung cancer in a North American population is involved to determine sample-related factors that influence success in clinical EGFR testing.
Journal ArticleDOI
PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings?
Kai-Liang Wu,Kai-Liang Wu,Yee C. Ung,Jennifer Hornby,Marc Freeman,David M. Hwang,Ming-Sound Tsao,Max Dahele,Gail Darling,Donna E. Maziak,Romeo Tirona,Kathy Mah,C. Shun Wong +12 more
TL;DR: Different PET CT threshold values were used for target delineation and then compared pathologically to find the MD of GTV(CT) had better correlation with the pathologic MD.
Journal Article
Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension.
TL;DR: In a case series of 4 patients with systemic sclerosis, concomitant PH, and biopsy-proven/presumed PVOD, treatment with an endothelin receptor antagonist did not confer a beneficial treatment effect.